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Abstract: Reverse microemulsion was used as a template to fabricate chitosan–alginate core-
shell nanoparticles encapsulated with enhanced green fluorescent protein (EGFP)-encoded 
plasmids. The average size of DNA-entrapped nanoparticles measured by dynamic light scattering 
was increased proportionally, with the N/P ratios ranging from 5 to 20. These alginate-coated 
chitosan nanoparticles endocytosed by NIH 3T3 cells trigged swelling of transport vesicles which 
render gene escape before entering digestive endolysosomal compartment and concomitantly 
promote gene transfection rate. Results showed that DNA-encapsulated chitosan–alginate 
nanoparticles with average size of 64 nm (N/P ratio of 5) could achieve the level of gene 
expression comparable with the one obtained by using polyethyleneimine–DNA complexes. 
Keywords: gene transfection, chitosan–alginate, core-shell, nanoparticles, reverse 
microemulsion, endocytosis 
Introduction
For the development of nonviral vectors to enhance gene-delivery efficiency, numerous 
synthetic chemicals, natural polymers, or lipids have been investigated for their potency 
(Quintanar-Guerrero et al 1998; Garnett 1999; Prokop et al 2002). Among them, 
chitosan as a cationic polysaccharide has been harnessed to construct nonviral gene 
delivery vehicles and antibacterial agents (Leong et al 1998; Mao et al 2001; Corsi 
et al 2003; Koping-Hoggard et al 2003; Qi et al 2004). However, gene transfection 
efficiency employing chitosan nanoparticles incorporated with DNA was inferior to the 
one using polyethyleneimine (PEI), poly-L-lysine (PLL), or cationic lipid (Mao et al 
2001; Corsi et al 2003; Mansouri et al 2004). For alginate, this anionic polysaccharide 
has been widely used in drug delivery but very few published accounts have discussed 
its merits for making particles of less than 100 nm for gene delivery. Until 2004, the 
gene transfection rate using gene carriers with Ca-alginate nanoparticles prepared by 
water-in-oil reverse microemulsion was as effective as using PEI–DNA complexes 
(You and Peng 2004). 
Although gene delivery efficacy attained by Ca-alginate nanoparticles is promising, 
it is limited by its fairly narrow transparent microemulsion domain for large-scale 
processes. In this study, we showed that the reverse microemulsion region can be easily 
enlarged using water-soluble chitosan (with MW of 8 kDa). This low-molecular-weight, 
positively charged chitosan was entangled with negatively charged plasmid carrying the 
enhanced green fluorescent protein (EGFP) gene, which then formed chitosan–DNA 
nanodroplets using reverse microemulsion as a template. To acquire solid nanoparticles, 
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chitosan–DNA nanodroplets via electrostatic attractions, 
and then was followed by the formation of Ca-alginate 
gel using Ca
2+ ion as the crosslinking agent. A plethora of 
chitosan–polyanion complexes has been investigated as drug-
delivery carriers (Lee et al 1998; Angelova and Hunkeler 
2001; Borchard 2001; Maurstad and Stokke 2004). Among 
them, the preparation of chitosan and alginate complex via 
electrostatic interaction is the one widely used (Mi et al 
2002; De and Robinson 2003; Zhang et al 2004; Douglas and 
Tabrizian 2005). However, chitosan–alginate nanoparticles 
with the core-shell morphology shown in this study have 
never been reported let alone used for drug and gene delivery. 
Furthermore, to visually observe the core-shell structure 
of chitosan–alginate nanoparticles, the fluorescent dye 
rhodamine and Lucifer yellow were used to label the inner-
layered chitosan and outer-layered Ca-alginate parts of the 
nanoparticle using carbodiimide chemicals, respectively.
The core-shell structured chitosan–alginate nanoparticles 
entrapped with plasmid DNA were used to transfect NIH 
3T3 fibroblast cells over 48 hours of culture. Swollen 
transport vesicles (eg, endosomes) were clearly apparent in 
cells 24 hours post incubation and the size and number of 
swollen vesicles progressively increased until 48 hours post 
incubation. The gene transfection result demonstrated that the 
chitosan–alginate core-shell nanoparticles as gene carriers 
can facilitate the escape of DNA from transport vesicles into 
cytosol, resulting in gene delivery efficiency comparable with 
that of widely used PEI–DNA complexes.
Materials and methods
Materials 
Chitosan (DD = 84%, mean MW 400 kDa) and iso-octane 
(2,2,4-trimethylpentane) were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). Sodium-alginate (medium viscosity; 
viscosity of 2% solution is approximately 2500 cps at 25°C), 
AOT (sodium bis(2-ethylhexyl) sulfosuccinate), calcium 
chloride, and PEI 50% w/v solution in water (mean MW 
750 kDa) were obtained from Sigma. Hydrogen peroxide 
(30% solution) was purchased from VWR (Bristol, CT, USA). 
5(6)-carboxy-x-rhodamine and Lucifer yellow potassium 
salt used to label nanoparticles were obtained from Sigma 
and Molecular Probes (Eugene, OR, USA), respectively. 
N-Hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethyl
aminopropyl)carbodiimide (EDAC) were purchased from 
Sigma. All of these materials were used without further 
purification. pEGFP-N1 vector was obtained from Clontech 
(Palo Alto, CA, USA). The murine fibroblast NIH 3T3 cell 
line was obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA). All other cell culture media 
and reagents were purchased from Irvine Scientific (Santa 
Ana, CA, USA).
setup of the phase diagram
Chitosan was depolymerized to 8 kDa with hydrogen 
peroxide, and the molecular weight was determined by 
the Mark-Houwink equation with Ubbelohde viscometer 
(Technical Glass Products, Painesville Twp., OH, USA). 
AOT and iso-octane were mixed with various ratios, and 
then 1 wt% chitosan solution was added dropwise into the 
AOT–isooctane mixture. Initially, the solution was clear and 
transparent. The mixture was defined as water-in-oil reverse 
microemulsion. With continuous addition of 1 wt% chitosan 
solution, the appearance of the mixture became translucent 
and then eventually milky. The ratios of iso-octane/chitosan 
solution/AOT that changed the appearance of such a mixture 
from transparent to translucent were used to determine 
the boundary line for differentiating microemulsion from 
emulsion.
Fabrication of chitosan–alginate  
core-shell nanoparticles
In order to obtain nanoparticles with a mean diameter 
less than 100 nm, chitosan–alginate nanoparticles were 
manufactured using water-in-oil reverse microemulsion as a 
template. Figure 1 illustrates the scheme of fabricating such 
types of nanomaterials as gene carriers. The continuous phase 
was formed by mixing 0.25 g AOT and 15 mL iso-octane with 
continuous stirring on a vortex mixer (Vortex-Genie2
TM). 
After AOT dissolved, 50 μL chitosan solution of particular 
concentration was dropped into the continuous phase while 
vortexing for 1 minute and then 10 μL 0.5 wt% sodium 
alginate solution was added into the continuous phase. To 
form solid nanoparticles, 2 mL of 0.1 wt% CaCl2 solution 
was added into the solution and mixed for another 5 minutes 
to establish crosslinked Ca-alginate gel on the surface of 
chitosan nanodroplets. Once the two phases were clearly 
separated, the nanoparticles suspended in the aqueous phase 
were pelleted out by ultracentrifugation at 33000 g for 25 
minutes (J2-21 centrifuge, JA 20.1 rotor, Beckman, Fullerton, 
CA, USA). 20% acetone solution was used to strip off AOT 
surfactant remaining on the nanoparticle surface. Finally, the 
pellet was washed with deionized water twice and stored at 
4°C for later use. international Journal of nanomedicine 2006:1(2) 175
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labeling of chitosan–alginate core-shell 
nanoparticles
The confocal images of fluorescent nanoparticles can 
demonstrate the structure of the nanoparticles. Therefore, the 
chitosan and alginate were labeled with different fluorescent 
dyes to reveal the structure of the nanoparticles. Furthermore, 
the particles were enlarged by confocal microscope for 
observation. 5(6)-carboxy-x-rhodamine used to label the 
amino groups on the chitosan for fluorescence measurement 
was prepared as follows: EDAC (0.1 g) and NHS (0.05 g) 
were dissolved in 1mL 0.1 M MES buffer with the pH 
adjusted to 6, and then 1 mg of 5(6)-carboxy-x-rhodamine 
was added. After 1 hour, 5 mg of chitosan was dropped into 
solution and reacted overnight. The labeled chitosan was 
purified with 8 kDa cut-off dialysis membrane, gathered, 
and freeze-dried. The labeled chitosan was used to form the 
core-shell nanoparticles instead of the unlabeled chitosan. 
After ultracentrifugation, EDAC (0.11 g) and NHS (0.055 g) 
were added into 1 mL of solution containing the nanoparticles 
and reacted for 2 hours. Then, 200 g of Lucifer yellow 
potassium salt dissolved in 400 μL deionized water was 
pipetted into the prepared nanoparticle-containing solution. 
After reaction overnight, the nanoparticles were washed with 
deionized water 3 times to remove the nonbound Lucifer 
yellow dye. The images of labeled nanoparticles were taken 




Chitosan solutions were prepared by dissolving the 
depolymerized chitosan in 50 μL deionized water to 
produce the chitosan solutions with various concentrations. 
The concentration of chitosan solution was determined 
according to the chosen ratio of amino nitrogens of chitosan 
and phosphate groups of plasmid DNA (so-called N/P 
ratio). The solutions were filtered under sterile conditions. 
Chitosan–DNA complexes were formulated by adding 2 μg 
pDNA into 0.1 mg/mL, 0.2 mg/mL, and 0.4 mg/mL chitosan 
solutions to obtain N/P ratios of 5, 10, and 20, respectively. 
The molar ratios of the aforementioned chitosan–alginate/
DNA samples were 50/10/1, 100/10/1, and 200/10/1, 
respectively. The procedure to obtain DNA-encapsulated 
chitosan–alginate nanoparticles was the same as that above, 
except that chitosan solution was replaced with the solution 
containing chitosan–DNA complexes.
size analysis of chitosan–alginate core-
shell nanoparticles
The particle-size distributions were determined by dynamic 
light scattering (DLS). The DLS measurement was performed 
by the DynaPro-99EMS/X instrument (Wyatt Technology 
Co., Santa Barbara, CA, USA) equipped with a solid-state 
laser operating at 655 nm with a temperature-controlled 
MicroSampler at 25°C. The autocorrelation function of 
the signal from the scattered intensity was measured by a 
multi-channel digital correlator. The particle-size distribution 
and the average particle diameter were obtained from the 
correlation function by a regularization method included in 
the data analysis software package (Dynamics V6.3.01). 
endocytosis of chitosan–alginate core-
shell nanoparticles
NIH 3T3 cells were used to explore the fate of chitosan–
alginate core-shell nanoparticles after entering cells through 
the endocytic pathway. 5 × 10
4 NIH 3T3 cells were cultured 
on 35-mm diameter glass-bottom tissue culture dishes 
(MatTek Co., Ashland, MA, USA) with 2 mL of high glucose 
Dulbecco’s modified Eagle medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS, Gibco BRL, Rockville, 
Figure 1  schematic illustration of chitosan–alginate core-shell nanoparticles 
prepared by reverse microemulsion template. Microemulsified chitosan 
nanoparticles were coated with na-alginate and then crosslinked by calcium 
chloride solution. aoT surfactants attached on the calcium-solidified 
microemulsions were stripped off using acetone and water 3 times. chitosan–
alginate core-shell nanoparticles were finally collected by ultracentrifugation.
Abbreviations: aoT, sodium bis(2-ethylhexyl) sulfosuccinate; W/o, water-in-oil. international Journal of nanomedicine 2006:1(2) 176
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MD, USA). After 24 hours’ pre-incubation, culture medium 
was replaced with chitosan–alginate core-shell nanoparticles 
suspended in fresh 2 mL DMEM plus 10% FBS. The cells 
were cultured for 2 days in an incubator at 37°C incubator 
balanced with 5% CO2. Cells were examined under bright-
field confocal microscopy (Zeiss LSM 510 META, Carl 
Zeiss Inc., Thornwood, NY, USA) at 24 hours and 48 hours 
post-incubation. Cell viability was determined using a 
hemocytometer with the trypan-blue exclusion method. 
gene transfection
NIH 3T3 cells in the exponential growth phase were detached 
with 1X ethylene-diamine tetra-acetic acid (EDTA) trypsin 
from a tissue culture dish (Falcon, Franklin Lakes, NJ, 
USA). 5 × 10
4 of NIH 3T3 cells were inoculated on 35-mm 
diameter glass-bottom culture dishes with 2 mL of DMEM 
supplemented with 10% FBS. After 24 hours’ incubation, 
chitosan–alginate core-shell nanoparticles encapsulated with 
2 μg of plasmid DNA encoding EGFP were suspended in 
2 mL of growth medium and layered on top of the adherent 
NIH 3T3 cells. NIH 3T3 cells exposed to DNA-encapsulated 
chitosan–alginate core-shell nanoparticles were incubated 
for gene transfection study. 24 hours and 48 hours after the 
addition of DNA-encapsulated chitosan–alginate core-shell 
nanoparticles, transfection efficiency was examined by 
counting cells expressing EGFP protein in 5 fluorescent con-
focal microscopic fields. For comparison, transfection of NIH 
3T3 cells was also performed using PEI–DNA complexes. 
Results and discussion
Determination of reverse 
microemulsion domain
A water-in-oil reverse microemulsion template was used 
to form chitosan nanoparticles. Because it is insoluble 
in the iso-octane phase, the chitosan solution has to be 
forced into the aqueous nanophase and stabilized by AOT 
surfactant. The domain of the stable microemulsion phase 
determined by varying the ratios of isooctane/chitosan 
solution/AOT is shown in Figure 2. The line plotted in the 
ternary phase diagram denotes the boundary between the 
region of microemulsion and emulsion. Point A stands for 
the microemulsion composition used for the fabrication of 
alginate-coated chitosan nanoparticles. With continuous 
addition of chitosan solution, the appearance of the mixture 
changed from transparent to translucent (vial B represents 
point B). Point B, located right on the boundary line, 
distinguishes the domain of microemulsion from that of 
emulsion. The amount of chitosan solution at point B was 
20 times more than the amount at point A, indicating that 
the nanoparticles fabricated in this study still had sufficient 
capacity to accommodate more chitosan solution. Compared 
with the microemulsion domain created by toluene–alginate 
solution–AOT, which has very narrow region (You and 
Peng 2004), the template system used here has much more 
operating space for making nanoparticles. Further addition 
of chitosan solution beyond point B created a milk-like 
mixture (vial C represents point C). It is noteworthy that 











Figure 2  Phase diagram for iso-octane/chitosan solution/aoT. Point a (iso-octane/chitosan solution/aoT=97.7:0.4:1.9 by weight) located in the water-in-oil 
microemulsion region showed the mixture was transparent. Point B (iso-octane/chitosan solution/aoT=90.0/8.3/1.7 by weight), which sits on the line indicating the 
interface between the microemulsion and emulsion domains, represents the translucent appearance of the mixture. With further addition of chitosan solution, the mixture 
turned into a milky emulsion (point c) (isooctane/chitosan solution/aoT=81.5/16.4/2.1 by weight). 
Abbreviations: aoT, sodium bis(2-ethylhexyl) sulfosuccinate.
(a)          (B)         (c)international Journal of nanomedicine 2006:1(2) 177
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gave rise to a larger microemulsion region than raw chitosan 
(ie, 400 kDa) (data not shown). Moreover, 8 kDa chitosan can 
be dissolved in water, unlike 400 kDa chitosan, which can 
be solubilized only in aqueous solution containing 2% acetic 
acid. It is clear that water-soluble chitosan is the preferred 
choice for making DNA-encapsulated nanoparticles for 
therapeutic applications. For large-scale production of 
nanoparticles using reverse microemulsion templates, the 
extent of the microemulsion domain plays a crucial role. 
Alginate-based nanoparticles previously made by the reverse 
microemulsion template were obtained by a very narrow 
domain of microemulsion (You and Peng 2004). Here, we 
demonstrate that the microemulsion region can be enlarged 
using 8 kDa chitosan rather than raw chitosan.
Photomicrographical images of labeled 
nanoparticles
Under fluorescence excitation light, the peak emission 
wavelengths of Lucifer yellow and 5(6)-carboxy-x-
rhodamine were 528 nm and 605 nm, respectively. Figure 3a 
shows the segment of the particle under 578 nm excitation 
light. Figure 3b shows the part of the particle under 425 nm 
excitation light. Figure 3c is a combination of the two 
previous pictures. 
effect of Dna encapsulation on 
nanoparticle size 
Both chitosan and alginate are adhesive hydrogel polymers 
(Robert et al 1988). Therefore, in aqueous solution, these 
nanoparticles interact among themselves through their 
Brownian motion to form clusters. The particle size increased 
with the increased amounts of chitosan and alginate solution. 
Also, the probability of inner-particle cross-linking through 
CaCl2 was also increased with the increased concentration 
of cross-linking agent (ie, Ca
2+). In order to prevent particle 
aggregation, the size of chitosan–alginate nanoparticles 
should be small and uniform. To examine if the size of 
nanoparticles would be affected by the encapsulation 
of DNA, the particle sizes of alginate-coated chitosan 
nanoparticles entrapped without and with plasmid DNA were 
measured. An N/P ratio of 5 was used for the formation of 
chitosan–DNA complexes. As shown in Figure 4, the particle 
size distributions ranged from 40 to 80 nm, and the mean 
particle size of chitosan–alginate nanoparticles with and 
without DNA were 64.0 and 60.1 nm, respectively. There 
was only a slight increase after encapsulating DNA into 
chitosan–alginate core-shell nanoparticles. Apparently, 2 μg 
of DNA entangled with chitosan is an appropriate selection 
which did not significantly increase the size of alginate-
coated nanoparticles.  
Figure 3  confocal images of chitosan–alginate core-shell nanoparticle structure. Figure 3a shows the alginate labeled with lucifer yellow, Figure 3b the chitosan labeled 

























Figure 4  Particle-size distribution of chitosan–alginate nanoparticles (■) and 
Dna-encapsulated chitosan–alginate nanoparticles (º). Under the same preparation 
conditions, the mean particle sizes with and without plasmid Dna were 64.0 nm 
and 60.1 nm, respectively.
a B cinternational Journal of nanomedicine 2006:1(2) 178
You et al
effect of n/P ratios on particle-size 
distribution
To study the influence of N/P ratio on particle size 
distribution, chitosan–alginate core-shell nanoparticles were 
prepared with 3 different N/P ratios: 5, 10, and 20, for a light 
scattering test. An increase in N/P ratio implied an increase 
in concentration of chitosan solution, since the DNA amount 
was fixed at 2 μg. Figure 5 reveals that the particle-size 
distribution shifted towards the right of the x-axis as the N/P 
ratio increased. The mean particle sizes of N/P=5, 10, and 20 
were 64.0, 69.5, and 80.6 nm, respectively. Obviously, even as 
the N/P ratio was raised from 5 to 20, the particle size was still 
less than 100 nm. This is consistent with the phase diagram 
(Figure 2) showing that the nanoparticles used in this study 
still have the capacity to incorporate more chitosan solution 
without a dramatic increase in particle size over 100 nm and 
without moving into the milky emulsion domain. 
Fate of chitosan–alginate core-shell 
nanoparticles after endocytosis
NIH 3T3 cells were incubated with chitosan–alginate core-
shell nanoparticles to examine the size evolution of the 
transport vesicles after 24 and 48 hours’ incubation. After 24 
and 48 hours, the dimension of transport vesicles increased 
to detectable vacuoles under an inverted bright-field confocal 
microscopy. As shown in Figure 6b, ingested nanoparticles 
led to slight swelling of vacuolar compartments, showing as 
bright white dots. These swollen vacuoles probably resulted 
from the erosion of Ca-alginate shell on chitosan–alginate 
core-shell nanoparticles causing high alginate concentration 
within transport vesicles and concomitant water influx (so-
called osmotic swelling). After 48 hours’ incubation, the size 
and number of vacuoles dramatically increased (Figure 6c). 
Although the size and number of swollen vacuoles increased 
after 48 hours, it should be noted that during the culture period 
cells retained their attaching and spreading morphology, with 
99% viability, and continued to grow and divide. 
efficiency of gene transfection
Figure 7A and B shows photomicrographical images of 
NIH 3T3 cells expressing EGFP under both bright-field and 
fluorescent confocal microscopy after 24 and 48 hours’ gene 
transfection. For comparison, transfection of NIH 3T3 cells 
was also performed using PEI–DNA complexes (Figure 7a 
and 7b) which are known to enhance DNA release from 
endosomes (Cho et al 2003). After 24 hours’ incubation, the 
transfection rate using PEI–DNA complexes (56%) was much 
higher than that for DNA-encapsulated chitosan–alginate 
core-shell nanoparticles (33%). However, after 48 hours’ 
incubation, the transfection rate using chitosan–alginate 

























Figure 5  The affect of chitosan solution concentration on particle-size 
distribution. The mean diameters of n/P = 5 (Δ), n/P = 10 (º), and n/P = 20 (■) were 
64.0, 69.5, and 80.6 nm, respectively. The amount of Dna used was fixed at 2 μg.
Figure 6  Photomicrographical images of nih 3T3 cells cultured with chitosan–alginate core-shell nanoparticles at various times. images were taken after (a) 0 hours, 
(b) 24 hours, and (c) 48 hours. The nanoparticles ingested into the endosomal compartments elicited the osmotic-swelling process over the period of cultivation. arrows 
indicate the location of swollen vacuoles harboring chitosan–alginate core-shell nanoparticles probably undergoing erosion. N = nucleus. scale bar = 5 μm.international Journal of nanomedicine 2006:1(2) 179
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up to 52% which is comparable with that using PEI–DNA 
complexes (57%). It is speculated that osmotic swelling of 
transport vesicles, elicited by the erosion of alginate coated 
on chitosan nanoparticles, reached its peak after 48 hours’ 
incubation, hence facilitating the release of encapsulated 
DNA into cytosol and resulting in the enhancement of 
transfection rate.
Conclusion
Chitosan–alginate core-shell nanoparticles were made 
using a water-in-oil reverse microemulsion template. 
Such biocompatible and biodegradable nanoparticles were 
used to encapsulate plasmid DNA for gene delivery via 
cell endocytosis pathway. After the introduction of DNA-
entrapped chitosan–alginate core-shell nanoparticles, the 
Ca-alginate shell was eroded from the nanoparticle through 
sequestering calcium ions by phosphate ions within the 
transport vesicles. This mechanism would enhance the 
concentration of alginate macromolecules within transport 
vesicles for eliciting osmotic swelling of the organelle and 
shortening the delivery time of intact DNA towards the 
nucleus for gene expression.
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